A MUC1-C–specific HLA-A24+ T-cell line derived from a patient with prostate cancer was stimulated using its specific MUC1 peptide and DCs treated with 0, 0.25 or 1.0 μM of epacadostat. This evidence concerns the gene MUC1 and prostate cancer.